Hemodynamic parameters. by Paulina Kania-Olejnik (19797617)

Subjects:

Tricuspid annular dimensions. by Paulina Kania-Olejnik (19797617)

Subjects:

Regional tricuspid annular perimeter. by Paulina Kania-Olejnik (19797617)

Subjects:

Tricuspid annular strain changes throughout the cardiac cycle during acute experimental atrial fibrillation. by Paulina Kania-Olejnik (19797617)

Subjects:

Tricuspid annular strain changes throughout the cardiac cycle during sinus rhythm. by Paulina Kania-Olejnik (19797617)

Subjects:

The annular area throughout the cardiac cycle in SR and AF. by Paulina Kania-Olejnik (19797617)

Subjects:

The location of the sonomicrometry crystals implanted on the tricuspid annulus, the right ventricle free wall, and the right ventricle apex. by Paulina Kania-Olejnik (19797617)

Subjects:

Global and regional average systolic tricuspid annular cardiac strains. by Paulina Kania-Olejnik (19797617)

Subjects:

Regional cardiac strain changes during cardiac cycle. by Paulina Kania-Olejnik (19797617)

Subjects:

Fig 6 - by Paulina Kania-Olejnik (19797617)

Subjects:

Fig 1 - by Eric Wikramanayake (4093231)

Subjects:

Land use and habitat categories in Mai Po Inner Deep Bay Ramsar site and Wetland Conservation Area cross-walked to SLAMM categories (based on SLAMM 6.7 technical documentation, Clo... by Eric Wikramanayake (4093231)

Subjects:

Variable Kinetic Isotope Effect Reveals a Multistep Pathway for Protonolysis of a Pt–Me Bond by Irving D. Rettig (14117340)

“…At lower concentrations of acid, the KIE decreased significantly (KIE = ∼6 for 0.1 mM (cod)PtMe₂ and 0.2 mM acid). …”

Expression of a phosphomimetic Hcm1 mutant decreases fitness in LiCl stress. by Michelle M. Conti (13514386)

Results of Analysis of Co-variance (ANCOVA) for change in parameter predicted by treatment group with pre-treatment value as a covariate. * p < 0.05; ** p < 0.01. by Lijuan Liu (136685)

Subjects:

Algorithm operation steps. by Junyan Wang (4738518)

“…Experimental results demonstrate that SCI-YOLO11 achieves a 3.2% improvement over baseline models in terms of MAP@0.5 metric; precision and recall rates increase by 2.6% and 3.7%, respectively. …”

Delphinidin alters VEGF-A splicing to increase VEGF-A₁₆₅b and decrease total VEGF-A expression. by Megan Stevens (3964886)

“…<p><b>A)</b> Treatment of podocytes with delphinidin chloride (10 μg/ml) under normal glucose (NG; 5 mM glucose + 25 mM mannitol) and high glucose (HG; 30 mM glucose, 1 ng/ml TNFα, 1 ng/ml IL-6, and 100 nM insulin) for 48 hrs increased the protein expression of VEGF-A₁₆₅b relative to total VEGF-A₁₆₅ (quantified in <b>B</b>; *p<0.05 vs NG, †p<0.05 vs HG; n = 3 biological repeats; One-way ANOVA with Bonferroni post-hoc test for comparison between pairs; <b>A</b>—the same blot was first probed with VEGF-A₁₆₅b before stripping and reprobing with panVEGF-A). …”

Flow chart of the expression-based functional screen, with validation steps. by Mohamad Karaky (8910497)

Subjects:

eIF5a is up-regulated in unruptured AAAs and decreased in ruptured AAAs. by Dong Ma (584680)

Subjects:

(A) Auxiliary marking points to ensure complete and accurate seating of the prosthesis. by Long Li (6555)

Subjects: